| Literature DB >> 25193234 |
William Tieu1, Angie M Jarrad2, Ashleigh S Paparella2, Kelly A Keeling3, Tatiana P Soares da Costa2, John C Wallace2, Grant W Booker2, Steven W Polyak2, Andrew D Abell4.
Abstract
Inhibitors of Staphylococcus aureus biotin protein ligase (SaBPL) are generated by replacing the acyl phosphate group of biotinyl-5'-AMP with either a 1,2,3-triazole (see 5/10a/10b) or a 1,2,4-oxadiazole (see 7) bioisostere. Importantly, the inhibitors are inactive against the human BPL. The nature of the 5-substituent in the component benzoxazolone of the optimum 1,2,3-triazole series is critical to activity, where this group binds in the ATP binding pocket of the enzyme.Entities:
Keywords: Antibiotics; Bioisosteres; Drug design; Inhibitors; Ligases
Mesh:
Substances:
Year: 2014 PMID: 25193234 DOI: 10.1016/j.bmcl.2014.08.030
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823